Moneycontrol Podcast / Coronavirus Essential | India's Covaxin may enter phase 3 trials in October; Bharat Biotech to make billion doses of intranasal vaccines

View our embed guidelines

Sorry, your browser isn't supported.

We recommend upgrading to the latest Chrome, Firefox, Safari, or Edge.

You can visit our support center if you're having problems.